Health CanadaGeneral Alert
Association of Relenza (zanamivir) Dry Powder for Inhalation with Fatal Outcome ...
Published: November 5, 2009Recall ID: 25431Category: generalCountry: Canada
Product Description & Identification
Association of Relenza (zanamivir) Dry Powder for Inhalation with Fatal Outcome when Administered by Nebulization Instead of Inhalation - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25431 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/association-relenza-zanamivir-dry-powder-inhalation-fatal-outcome-when-administered |
| Title | Association of Relenza (zanamivir) Dry Powder for Inhalation with Fatal Outcome when Administered by Nebulization Instead of Inhalation - Notice to Hospitals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2009-11-05 |
| Organization | Marketed health products |